首页> 美国卫生研究院文献>International Journal of Environmental Research and Public Health >Surveillance and Correlation of Antibiotic Consumption and Resistance of Acinetobacter baumannii complex in a Tertiary Care Hospital in Northeast China 2003–2011
【2h】

Surveillance and Correlation of Antibiotic Consumption and Resistance of Acinetobacter baumannii complex in a Tertiary Care Hospital in Northeast China 2003–2011

机译:东北三级医院2003年至2011年鲍曼不动杆菌抗生素消费量与耐药性的监测及其相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study investigated the changes in resistance of Acinetobacter baumannii complex and the association of carbapenem-resistant A. baumannii complex (CRAB) infection and hospital antimicrobial usage from 2003 to 2011 in a tertiary care hospital in northeast China. In vitro susceptibilities were determined by disk diffusion test and susceptibility profiles were determined using zone diameter interpretive criteria, as recommended by the Clinical and Laboratory Standards Institute (CLSI). Data on consumption of various antimicrobial agents, expressed as defined daily dose/1,000 patients/day, were collected retrospectively from hospital pharmacy computer database. Most of 2,485 strains of A. baumannii complex were collected from respiratory samples (1,618 isolates, 65.1%), secretions and pus (465, 18.7%) over the years. The rates of antimicrobial resistance in A. baumannii complex increased significantly over the years. The rates of CRAB were between 11.3% and 59.1% over the years. The quarterly use of anti-pseudomonal carbapenems, but not other classes of antibiotics, was strongly correlated with the increase of quarterly CRAB (β = 1.661; p < 0.001). Dedicated use of anti-pseudomonal carbapenems would be an important intervention to control the increase of CRAB.
机译:本研究调查了2003年至2011年在中国东北地区的一家三级医院中鲍曼不动杆菌复合物耐药性的变化以及耐碳青霉烯鲍曼不动杆菌复合物(CRAB)感染与医院抗菌药物使用的相关性。根据临床和实验室标准协会(CLSI)的建议,通过纸片扩散测试确定体外药敏性,并使用区域直径解释性标准确定药敏性。回顾性地从医院药房计算机数据库中收集各种抗菌药物的消耗数据,以定义的每日剂量/ 1,000名患者/天表示。这些年来,从呼吸道样本(1,618株,占65.1%),分泌物和脓液(465,18.7%)中收集了2,485株鲍曼不动杆菌复合物的大部分。这些年来,鲍曼不动杆菌复合物中的抗微生物药耐药率显着提高。多年来,CRAB的比率在11.3%至59.1%之间。每季度使用一次抗假单胞菌碳青霉烯类药物,而不是其他种类的抗生素,与每季度CRAB的增加密切相关(β= 1.661; p <0.001)。专门使用抗假单胞菌碳青霉烯类化合物将是控制CRAB升高的重要干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号